Keywords: AML، لوسمی میلوئیدی حاد; AML, acute myeloid leukaemia; MS, myeloid sarcoma; SBCE, small bowel capsule endoscopyAcute leukaemia; Capsule endoscopy; Chloroma; Granulocytic sarcoma; Myeloid sarcoma; Small-bowel
مقالات ISI AML، لوسمی میلوئیدی حاد (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: AML، لوسمی میلوئیدی حاد; AML, Acute myeloid leukaemia; DDS, Drug delivery system; DNR, Daunorubicin; DOX, Doxorubicin; Eme, Emetine; FA, Folate; FR2, Folic acid receptor 2 (β); HEPC, Hydrogenated egg phosphatidylcholine; MTX, Methotrexate; PE, Phosphatidylethanolamine; PEG, Polye
Keywords: AML، لوسمی میلوئیدی حاد; AML, acute myeloid leukaemia; AraC, Cytarabine; BIR, Baculovirus IAP Repeat; CBF, core-binding factor; CI, combination index; cIAP1, cellular inhibitor of apoptosis protein 1; FACS, fluorescence-activated cell-sorting; FADD, FAS-associated death domain pr
Preclinical pharmacokinetic studies of 3-deazaneplanocin A, a potent epigenetic anticancer agent, and its human pharmacokinetic prediction using GastroPlus™
Keywords: AML، لوسمی میلوئیدی حاد; AML, acute myeloid leukaemia; ANOVA, one-way analysis of variance; AUC, area under the concentration–time curve; BSA, body surface area; BUN, blood urea nitrogen; BW, body weight; B/P, blood-to-plasma; CL, total plasma clearance; CLr, renal clearance; Cma
A clinical comparison of the efficacy and safety of biosimilar G-CSF and originator G-CSF in haematopoietic stem cell mobilization
Keywords: AML، لوسمی میلوئیدی حاد; AHSCT, autologous haematopoietic stem cell transplantation; ALL, acute lymphoblastic leukaemia; AML, acute myeloid leukaemia; CD, cluster differentiation; CTC v.4, common toxicity criteria version 4; DLBCL, diffuse large B-cell lymphoma; ESHAP, etoposide,
The role of miRNA-29 family in cancer
Keywords: AML، لوسمی میلوئیدی حاد; miRNA, microRNA; CEBPA, enhancer-binding protein-α; AML, acute myeloid leukaemia; TLRs, Toll-like receptors; TGF-β, transforming growth factor-β; EMT, epithelial–mesenchymal transition; MCL, mantle cell lymphoma; LSC, leukemia stem cells; HDAC, histone de
Long-lived fusions of human haematological tumour cells and B-lymphoblastoid cells induce tumour antigen-specific cytotoxic T-cell responses in vitro
Keywords: AML، لوسمی میلوئیدی حاد; ALL, acute lymphoblastic leukaemia; AML, acute myeloid leukaemia; APC, antigen presenting cell; CTL, cytotoxic T cell; DC, dendritic cell; EBV, Epstein–Barr virus; HAT, hypoxanthine, aminopterin, thymidine; HLA, human leukocyte antigen; LCL, lymphoblastoi
BCR/ABL modulates protein phosphorylation associated with the etoposide-induced DNA damage response
Keywords: AML، لوسمی میلوئیدی حاد; AML, acute myeloid leukaemia; CML, chronic myeloid leukaemia; DSBs, double strand breaks; NFκB, nuclear factor kappa B; PTK, protein tyrosine kinase; TiO2, titanium dioxide; NHEJ, non-homologous end joining; HR, homologous recombination; SSA, single-stran
Prognosis of patients with haematological malignancies admitted to the intensive care unit: Sequential Organ Failure Assessment (SOFA) trend is a powerful predictor of mortality
Keywords: AML، لوسمی میلوئیدی حاد; ICU, intensive care unit; APACHE-II, Acute Physiology and Chronic Health Evaluation II; SOFA, Sequential Organ Failure Assessment; AML, acute myeloid leukaemia; SCT, stem cell transplantation; OR, odds ratioHaematological malignancy; Intensive care; Criti
Gender-linked haematopoietic and metabolic disturbances induced by a pesticide mixture administered at low dose to mice
Keywords: AML، لوسمی میلوئیدی حاد; AML, acute myeloid leukaemia; BFU-E, burst forming unit-erythrocyte; BSA, Bovine Serum Albumin; CFU-GM, colony forming unit-granulocyte macrophage; CFU-M, colony forming unit-macrophage; FBS, Foetal Bovine Serum; GSK3β, Glycogen Synthase Kinase3β; LDA, Li
Clinical management of myelodysplastic syndromes: update of SIE, SIES, GITMO practice guidelines
Keywords: AML، لوسمی میلوئیدی حاد; AML, acute myeloid leukaemia; BM, bone marrow; CB, cord blood; DLI, donor leukocyte infusion; EBMT, European blood and marrow transplantation; EWOG-MDS, European Working Group on Childhood Myelodysplastic Syndromes; G-CSF, granulocyte colony stimulating f
Negative immunomagnetic selection of T cells from peripheral blood of presentation AML specimens
Keywords: AML، لوسمی میلوئیدی حاد; AML, acute myeloid leukaemia; PBMC, peripheral blood mononuclear cells; PB, peripheral blood; FACS, fluorescence-activated cell sorting; NK, natural killerT cell; AML; Immunomagnetic selection
Profiling CD antigens on leukaemias with an antibody microarray
Keywords: AML، لوسمی میلوئیدی حاد; ALL, acute lymphocytic leukaemia; AML, acute myeloid leukaemia; APL, acute promyelocytic leukaemia; ATRA, all-trans retinoic acid; BMA, bone marrow aspirate; CD antigen, cluster of differentiation antigen; CEA, chorio-embryonic antigen; CLL, chronic lymph
SSX2IP: An emerging role in cancer
Keywords: AML، لوسمی میلوئیدی حاد; ADIP, afadin DIL domain-interacting protein; AJ, adherens junctions; AML, acute myeloid leukaemia; LCG, light-inducible and clock-controlled gene; SSX2IP, Synovial Sarcoma X breakpoint 2 Interacting ProteinSSX2IP; ADIP; LCG; Cell cycle; Immunotherapy; Leu
RAD51 homologous recombination repair gene haplotypes and risk of acute myeloid leukaemia
Keywords: AML، لوسمی میلوئیدی حاد; AML, acute myeloid leukaemia; DSB, double strand break; HR, homologous recombination; NHEJ, non-homologous end joining; FA, Fanconi's anemia; OR, odds ratio; CI, confidence intervalAcute myeloid leukaemia; DNA repair; Double strand break; Homologous recom
Methylation damage response in hematopoietic progenitor cells
Keywords: AML، لوسمی میلوئیدی حاد; HSCs, hematopoietic stem cells; MNU, N-methyl-N-nitrosourea; MMR, mismatch repair; BER, base excision repair; AML, acute myeloid leukaemia; NER, nucleotide excision repair; DSBs, double strand breaks; ENU, ethylnitrosourea; O6-meG, O6-methylguanine; O6MGM
Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells
Keywords: AML، لوسمی میلوئیدی حاد; AML, acute myeloid leukaemia; Ara-C, cytarabine; ELISA, enzyme-linked immunoassay; SCF, stem cell factorAML; Apoptosis; Bcl-2; CD34+; Chemotherapy; Cytarabine; Daunorubicin; Elderly; Flow cytometry; Myeloid leukaemia
Increased expression of cyclin A1 protein is associated with all-trans retinoic acid-induced apoptosis
Keywords: AML، لوسمی میلوئیدی حاد; AML, acute myeloid leukaemia; ATRA, all-trans retinoic acid; CDK, cyclin dependent kinase; CDKI, cyclin dependent kinase inhibitor; CHX, cycloheximide; TUNEL, terminal deoxynucleotidyl transferase-mediated dUTP nick-end-labelingCyclin A1; All-trans retino
A Fas agonist induces high levels of apoptosis in haematological malignancies
Keywords: AML، لوسمی میلوئیدی حاد; 7AAD, 7-aminoactinomycin D; ALL, acute lymphoblastic leukaemia; AML, acute myeloid leukaemia; CLL, chronic lymphocytic leukaemia; CML, chronic myeloid leukaemia; FCS, fetal calf serum; IC50, inhibitory concentration of 50% of cells; MFI, mean fluorescence
Deregulated NF-κB activity in haematological malignancies
Keywords: AML، لوسمی میلوئیدی حاد; ABC, activated B-cell-like; ALCL, anaplastic large cell lymphoma; ALL, acute lymphoblastic leukaemia; AML, acute myeloid leukaemia; BAFF, B cell-activating factor; BCL-2, B-cell lymphoma 2; B-CLL, B-cell chronic lymphocytic leukemia; BCR, B-cell receptor;